Ambrx Biopharma Inc. Deferred Revenue
Ambrx Biopharma Inc. had Deferred Revenue of $407.00 thousand as of 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2023-08-09
- 2023-06-30: Deferred Revenue, Current $407.00K.
- 2023-03-31: Deferred Revenue, Current $407.00K.
- 2022-12-31: Deferred Revenue, Current $407.00K.
- 2022-06-30: Deferred Revenue, Current $3.14M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2023-06-30 | $407.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $407.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $407.00K 10-Q · filed 2023-08-09 |
| 2022-06-30 | $3.14M 6-K · filed 2022-08-29 |
| 2021-12-31 | $4.27M 10-K · filed 2023-03-30 |
| 2020-12-31 | $6.47M 20-F · filed 2022-04-26 |